Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance.
Pulluri, Bhargavi
Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance. [electronic resource] - Pharmacological research Sep 2017 - 95-102 p. digital
Publication Type: Journal Article; Review
1096-1186
10.1016/j.phrs.2017.07.006 doi
Animals
Drug Resistance, Neoplasm
Humans
Immunotherapy
Melanoma--drug therapy
Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors
Proto-Oncogene Proteins B-raf--antagonists & inhibitors
Tumor Microenvironment
Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance. [electronic resource] - Pharmacological research Sep 2017 - 95-102 p. digital
Publication Type: Journal Article; Review
1096-1186
10.1016/j.phrs.2017.07.006 doi
Animals
Drug Resistance, Neoplasm
Humans
Immunotherapy
Melanoma--drug therapy
Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors
Proto-Oncogene Proteins B-raf--antagonists & inhibitors
Tumor Microenvironment